SeaStar Medical Valuation
| ICU Stock | USD 2.44 0.03 1.24% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. SeaStar Medical Holding has a current Real Value of $4.03 per share. The regular price of the company is $2.44. Our model measures the value of SeaStar Medical Holding from inspecting the company fundamentals such as Return On Equity of -2.9, current valuation of 4.19 M, and Shares Owned By Insiders of 2.58 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting SeaStar Medical's valuation include:
Price Book 0.7955 | Enterprise Value | Enterprise Value Ebitda (8.13) | Price Sales 10.395 | Enterprise Value Revenue 4.7526 |
Undervalued
Today
Please note that SeaStar Medical's price fluctuation is very risky at this time. Calculation of the real value of SeaStar Medical Holding is based on 3 months time horizon. Increasing SeaStar Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
SeaStar Medical's intrinsic value may or may not be the same as its current market price of 2.44, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.44 | Real 4.03 | Target 9.0 | Hype 2.43 | Naive 2.56 |
The intrinsic value of SeaStar Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence SeaStar Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of SeaStar Medical Holding helps investors to forecast how SeaStar stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SeaStar Medical more accurately as focusing exclusively on SeaStar Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use SeaStar Medical's intrinsic value based on its ongoing forecasts of SeaStar Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against SeaStar Medical's closest peers.
SeaStar Medical Cash |
|
SeaStar Medical Total Value Analysis
SeaStar Medical Holding is currently forecasted to have company total value of 4.19 M with market capitalization of 9.16 M, debt of 574 K, and cash on hands of 49 K. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the SeaStar Medical fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.19 M | 9.16 M | 574 K | 49 K |
SeaStar Medical Investor Information
The company has price-to-book (P/B) ratio of 0.8. Some equities with similar Price to Book (P/B) outperform the market in the long run. SeaStar Medical Holding recorded a loss per share of 11.3. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 5th of January 2026. SeaStar Medical Holding may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.SeaStar Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. SeaStar Medical has an asset utilization ratio of 2.9 percent. This implies that the Company is making $0.029 for each dollar of assets. An increasing asset utilization means that SeaStar Medical Holding is more efficient with each dollar of assets it utilizes for everyday operations.SeaStar Medical Profitability Analysis
Taking into consideration SeaStar Medical's profitability measurements, SeaStar Medical Holding may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess SeaStar Medical's ability to earn profits and add value for shareholders.Net Loss | First Reported 2020-12-31 | Previous Quarter -2 M | Current Value -3.5 M | Quarterly Volatility 3.5 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 10.75 | 10.24 |
|
|
For SeaStar Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of SeaStar Medical Holding to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well SeaStar Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between SeaStar Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of SeaStar Medical over time as well as its relative position and ranking within its peers.
SeaStar Medical Earnings per Share Projection vs Actual
The next projected EPS of SeaStar Medical is estimated to be -1.53625 with future projections ranging from a low of -1.585 to a high of -1.4875. SeaStar Medical's most recent 12-month trailing earnings per share (EPS TTM) is at -11.3. Please be aware that the consensus of earnings estimates for SeaStar Medical Holding is based on EPS before non-recurring items and includes expenses related to employee stock options.SeaStar Medical Earnings Estimation Breakdown
The calculation of SeaStar Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of SeaStar Medical is estimated to be -1.53625 with the future projection ranging from a low of -1.585 to a high of -1.4875. Please be aware that this consensus of annual earnings estimates for SeaStar Medical Holding is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-1.58 Lowest | Expected EPS | -1.49 Highest |
SeaStar Medical Earnings Projection Consensus
Suppose the current estimates of SeaStar Medical's value are higher than the current market price of the SeaStar Medical stock. In this case, investors may conclude that SeaStar Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and SeaStar Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 1 | 19.32% | -0.13 | -1.53625 | -11.3 |
SeaStar Medical Ownership Allocation
About 91.14 % of SeaStar Medical outstanding shares are held by general public with 2.58 (%) owned by insiders and only 6.28 % by institutional holders.SeaStar Medical Profitability Analysis
The company reported the last year's revenue of 135 K. Reported Net Loss for the year was (24.83 M) with profit before taxes, overhead, and interest of 840 K.About SeaStar Medical Valuation
The stock valuation mechanism determines SeaStar Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of SeaStar Medical Holding based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of SeaStar Medical. We calculate exposure to SeaStar Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SeaStar Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 155.2 K | 163 K | |
| Pretax Profit Margin | (165.51) | (173.79) | |
| Operating Profit Margin | (118.95) | (124.89) | |
| Net Loss | (165.53) | (173.81) |
SeaStar Medical Current Valuation Indicators
SeaStar Medical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final SeaStar Medical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as SeaStar Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use SeaStar Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes SeaStar Medical's worth.Additional Tools for SeaStar Stock Analysis
When running SeaStar Medical's price analysis, check to measure SeaStar Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SeaStar Medical is operating at the current time. Most of SeaStar Medical's value examination focuses on studying past and present price action to predict the probability of SeaStar Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SeaStar Medical's price. Additionally, you may evaluate how the addition of SeaStar Medical to your portfolios can decrease your overall portfolio volatility.